Table 1.

Multivariate analysis for ovarian tumor group status versus clinical risk factors, including proliferation, stage, grade, age, and survival

DatasetTissue typeAnalysis groupSurvival dataStatistical significanceaHR (95% CI)
GSE9891OvarianTothillOS0.054811.9 (0.9869–3.657)
DTFOS0.899021.037 (0.5928–1.814)
ProliferationOS0.712031.106 (0.6487–1.885)
StageOS0.00372**1.774 (1.2043–2.612)
GradeOS0.748331.059 (0.7472–1.5)
AgeOS0.00758**1.029 (1.0075–1.05)
GSE9891OvarianTothillRFS0.0661.6546 (0.9673–2.83)
DTFRFS0.2841.2744 (0.8179–1.986)
ProliferationRFS0.8270.9542 (0.6272–1.452)
StageRFS0.00000382***1.9462 (1.4674–2.581)
GradeRFS0.3931.121 (0.8625–1.457)
AgeRFS0.0781.0144 (0.9984–1.031)
TCGAOvarianTothillOS0.1659180.7029 (0.4269–1.157)
DTFOS0.1170831.4147 (0.9167–2.183)
ProliferationOS0.9964110.9991 (0.6719–1.486)
StageOS0.008118**1.4474 (1.1007–1.903)
GradeOS0.136251.3227 (0.9155–1.911)
AgeOS0.000564***1.0206 (1.0088–1.032)
TCGAOvarianTothillPFS0.01411*0.5457 (0.3364–0.8851)
DTFPFS0.00177**1.9542 (1.2839–2.9744)
ProliferationPFS0.456040.864 (0.5883–1.269)
StagePFS0.00707**1.4398 (1.1044–1.8771)
GradePFS0.188771.26 (0.8926–1.7787)
AgePFS0.549741.0033 (0.9925–1.0143)
  • a *, P < 0.05; **, P < 0.01; ***, P < 0.001.